Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
27873386
DOI
10.1111/ene.13200
Knihovny.cz E-zdroje
- Klíčová slova
- Brief International Cognitive Assessment for Multiple Sclerosis, MRI, brain atrophy, cognition, lesions, multiple sclerosis,
- MeSH
- atrofie diagnostické zobrazování patologie MeSH
- dospělí MeSH
- kognitivní dysfunkce diagnostické zobrazování patologie psychologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- mozek diagnostické zobrazování patologie MeSH
- neuropsychologické testy MeSH
- roztroušená skleróza diagnostické zobrazování patologie psychologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND AND PURPOSE: While impaired cognitive performance is common in multiple sclerosis (MS), it has been largely underdiagnosed. Here a magnetic resonance imaging (MRI) screening algorithm is proposed to identify patients at highest risk of cognitive impairment. The objective was to examine whether assessment of lesion burden together with whole brain atrophy on MRI improves our ability to identify cognitively impaired MS patients. METHODS: Of the 1253 patients enrolled in the study, 1052 patients with all cognitive, volumetric MRI and clinical data available were included in the analysis. Brain MRI and neuropsychological assessment with the Brief International Cognitive Assessment for Multiple Sclerosis were performed. Multivariable logistic regression and individual prediction analysis were used to investigate the associations between MRI markers and cognitive impairment. The results of the primary analysis were validated at two subsequent time points (months 12 and 24). RESULTS: The prevalence of cognitive impairment was greater in patients with low brain parenchymal fraction (BPF) (<0.85) and high T2 lesion volume (T2-LV) (>3.5 ml) than in patients with high BPF (>0.85) and low T2-LV (<3.5 ml), with an odds ratio (OR) of 6.5 (95% CI 4.4-9.5). Low BPF together with high T2-LV identified in 270 (25.7%) patients predicted cognitive impairment with 83% specificity, 82% negative predictive value, 51% sensitivity and 75% overall accuracy. The risk of confirmed cognitive decline over the follow-up was greater in patients with high T2-LV (OR 2.1; 95% CI 1.1-3.8) and low BPF (OR 2.6; 95% CI 1.4-4.7). CONCLUSIONS: The integrated MRI assessment of lesion burden and brain atrophy may improve the stratification of MS patients who may benefit from cognitive assessment.
Department of Health Sciences University of Genoa Genoa Italy
Department of Medicine University of Melbourne Melbourne Vic Australia
Department of Neurology Royal Melbourne Hospital Melbourne Vic Australia
Department of Statistics and Probability University of Economics Prague Prague Czech Republic
Citace poskytuje Crossref.org
Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis
Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
Cognitive clinico-radiological paradox in early stages of multiple sclerosis